Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × apatinib × Gastrointestinal × Clear all

Phase

Status

Unknown 99 Recruiting 25 Completed 22 Not yet recruiting 14 Active not recruiting 8 Terminated 4 Withdrawn 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Gemcitabine 6 Bevacizumab 5 Oxaliplatin 4 Capecitabine 4 atezolizumab 3 Specimen Handling 3 S 1 (combination) 3 Leucovorin 3 Irinotecan 3 Fluorouracil 3 Drug Therapy 3 trifluridine tipiracil drug combination 2 titanium silicide 2 spartalizumab 2 lenvatinib 2 Radiotherapy 2 Nivolumab 2 Immunotherapy 2 Endoscopic Mucosal Resection 2 Cyclophosphamide 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vactosertib 1 tucatinib 1 tivozanib 1 sotigalimab 1 sodium thiosulfate 1 rhenium-SSS-lipiodol 1 regorafenib 1 poly(I).poly(c12,U) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03743428 2023-06-29

BABST-C

Shenzhen People's Hospital

Phase NA Suspended

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡